INO

#4129
Inovio Pharmaceuticals, Inc.
1.11 USD
+1.83%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
1.11
1.11
Intervallo Annuale
1.03
2.98
Variazione giornaliera
+1.83%
Variazione Mensile
-33.53%
Variazione di 6 mesi
-55.24%
Variazione Annuale
-37.29%
Chiusura Precedente
1.09
Apertura
1.11
Bid
Ask
Minimo
1.11
High
1.11
Volume
16
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 76.69 M
  • Employee 112
  • Founded 1999
  • CEO Jacqueline Shea
  • Website www.inovio.com
  • Headquarter Delaware, United States
  • FIGI BBG000BK6YX5
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.96
Rapporto prezzo/fatturato
1 248.52

Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development.

Notizie